Morgan Stanley’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18B | Buy |
|
|||||
|
2025
Q1 | $1.29B | Buy |
|
|||||
|
2024
Q4 | $1.06B | Sell |
|
|||||
|
2024
Q3 | $1.8B | Buy |
|
|||||
|
2024
Q2 | $1.75B | Buy |
|
|||||
|
2024
Q1 | $1.53B | Sell |
|
|||||
|
2023
Q4 | $2.74B | Buy |
|
|||||
|
2023
Q3 | $1.21B | Buy |
|
|||||
|
2023
Q2 | $1.22B | Sell |
|
|||||
|
2023
Q1 | $1.27B | Sell |
|
|||||
|
2022
Q4 | $1.51B | Buy |
|
|||||
|
2022
Q3 | $1.13B | Buy |
|
|||||
|
2022
Q2 | $1.19B | Buy |
|
|||||
|
2022
Q1 | $727M | Sell |
|
|||||
|
2021
Q4 | $789M | Buy |
|
|||||
|
2021
Q3 | $615M | Buy |
|
|||||
|
2021
Q2 | $599M | Buy |
|
|||||
|
2021
Q1 | $522M | Sell |
|
|||||
|
2020
Q4 | $501M | Buy |
|
|||||
|
2020
Q3 | $345M | Buy |
|
|||||
|
2020
Q2 | $329M | Sell |
|
|||||
|
2020
Q1 | $305M | Buy |
|
|||||
|
2019
Q4 | $384M | Buy |
|
|||||
|
2019
Q3 | $304M | Buy |
|
|||||
|
2019
Q2 | $334M | Buy |
|
|||||
|
2019
Q1 | $231M | Sell |
|
|||||
|
2018
Q4 | $250M | Buy |
|
|||||
|
2018
Q3 | $185M | Buy |
|
|||||
|
2018
Q2 | $97.1M | Sell |
|
|||||
|
2018
Q1 | $98M | Sell |
|
|||||
|
2017
Q4 | $132M | Sell |
|
|||||
|
2017
Q3 | $136M | Buy |
|
|||||
|
2017
Q2 | $114M | Sell |
|
|||||
|
2017
Q1 | $164M | Buy |
|
|||||
|
2016
Q4 | $122M | Buy |
|
|||||
|
2016
Q3 | $63M | Buy |
|
|||||
|
2016
Q2 | $63.4M | Buy |
|
|||||
|
2016
Q1 | $56.5M | Sell |
|
|||||
|
2015
Q4 | $67.6M | Buy |
|
|||||
|
2015
Q3 | $63.7M | Sell |
|
|||||
|
2015
Q2 | $193M | Buy |
|
|||||
|
2015
Q1 | $109M | Sell |
|
|||||
|
2014
Q4 | $179M | Buy |
|
|||||
|
2014
Q3 | $129M | Buy |
|
|||||
|
2014
Q2 | $98.3M | Buy |
|
|||||
|
2014
Q1 | $88.1M | Sell |
|
|||||
|
2013
Q4 | $90.9M | Buy |
|
|||||
|
2013
Q3 | $78.9M | Buy |
|
|||||
|
2013
Q2 | $69.7M | Buy |
|